Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
SISI-BONE, Inc. logo

SI-BONE, Inc. (SIBN)

NASDAQ Global Market · Currency in USD
$21.48 ▼ -0.08 (-0.37%)
At close: Oct 23, 4:00 PM ET. Market closed.
$21.48 ▲ +0.00 (+0.00%)
After hours: Oct 23, 7:30 PM ET

Summary

Previous Close
$21.56
Open
$21.21
Day's Range
$20.67 – $21.63
52 Week Range
$11.48 – $21.89
Volume
469,087
Avg. Volume
579,129
Market Cap
$962.70M
Beta (5Y Monthly)
0.66
PE Ratio (TTM)
--
EPS (TTM)
-$0.33
Earnings Date
Nov 2, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$23.00

Profile: SI-BONE, Inc.

Sector
Healthcare
Industry
Medical - Devices
Full-time employees
376
CEO
Laura A. Francis

SI-BONE, Inc. is a medical technology company that develops and markets specialized implantable solutions for musculoskeletal conditions affecting the sacropelvic region. These devices are utilized across the United States and internationally. Its flagship product, iFuse, is a minimally invasive surgical implant system designed to address a range of indications, including sacroiliac joint dysfunction and degeneration, adult spinal deformities, and traumatic fractures of the pelvic ring.

Earnings

Next report: Mon, Nov 2, 2026
EPS estimate -$0.13 · Revenue est. $55.31M
DateEst.Actual
Aug 3, 2026-$0.15-$0.09Beat
May 11, 2026-$0.17-$0.10Beat
Feb 23, 2026-$0.13-$0.04Beat
Nov 10, 2025-$0.16-$0.11Beat
Aug 4, 2025-$0.19-$0.14Beat
May 5, 2025-$0.24-$0.15Beat

Analyst view

Consensus price target
$23.00 ▲ +7.1%
Range $21.00 – $25.00
Rating: Buy
Buy 100% · Hold 0% · Sell 0%

Get free alerts on SIBN and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.